Autoplaque vs 1CMR Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

1CMR Pro

by Mycardium AI Limited

AI Verdict

Autoplaque specializes in the quantitative analysis of coronary plaques and luminal stenoses using CT angiography images for heart attack risk prediction. In contrast, 1CMR Pro is an AI-enhanced reporting software designed to improve the speed and precision of measurements from Cardiac MRI scans. While both are valuable cardiology AI tools, their focus on distinct imaging modalities makes them complementary rather than direct competitors.

Choose Autoplaque if…

Choose Autoplaque if your primary need is AI-powered quantitative analysis of coronary plaques and luminal stenoses directly from CT angiography images. This tool is ideal for clinicians focused on detailed characterization of atherosclerotic plaque to aid in heart attack risk prediction and treatment guidance, offering workstation-based post-processing with editable segmentations.

View Autoplaque →

Choose 1CMR Pro if…

Choose 1CMR Pro if you require highly precise and consistent cardiac MRI analysis, especially for automated volumetric and functional measurements. This software is best suited for institutions prioritizing local data processing and seeking to enhance the speed, accuracy, and reproducibility of cardiac MRI reporting, with the flexibility for clinicians to review and edit AI-generated contours.

View 1CMR Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	1CMR Pro
Pricing	Unknown	Contact for pricing
Deployment	Workstation-based post-processing application, runs on Windows or Mac OS.	On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform)
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	1CMR Pro
Product Name	Autoplaque	1CMR Pro
Company	Cedars-Sinai Medical Center: AIM	Mycardium AI Limited
Primary Function	AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance.	AI-enhanced Cardiac MRI reporting software that delivers up to 40% more precise measurements, enabling faster and more consistent cardiac MRI analysis.
Regulatory Clearance	FDA-cleared	FDA 510(k) cleared and CE Class IIB cleared
Target Imaging Modality	CT Angiography (CTA) images	Cardiac MRI (CMR)
Key Analysis Capabilities	AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses; Automated vessel, plaque, and lumen segmentation.	AI-enhanced Cardiac MRI Reporting; Automated volumetric and functional measurements; Transparent and editable contours for clinician control; Regulatory-grade automation for enhanced precision and reproducibility.

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and 1CMR Pro.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiac imaging modalities does each tool analyze?

Autoplaque is designed for quantitative analysis of coronary plaques and luminal stenoses from CT angiography (CTA) images, aiding in heart attack risk prediction and treatment guidance. In contrast, 1CMR Pro is an AI-enhanced cardiac MRI (CMR) reporting software that delivers automated volumetric and functional measurements.

What are the primary clinical applications and benefits of each software?

Autoplaque's primary application is the detection and characterization of coronary artery plaque and the measurement of luminal stenoses from CTA images to help predict heart attack risk and guide treatment. 1CMR Pro focuses on enhancing cardiac MRI analysis by providing faster, more consistent, and up to 40% more precise volumetric and functional measurements than manual analysis for cardiac MRI reporting.

Do both tools allow clinicians to review and edit AI-generated results?

Yes, both tools incorporate clinician control. Autoplaque offers automated vessel, plaque, and lumen segmentation that is reviewable and editable by a clinician. Similarly, 1CMR Pro provides transparent and editable contours, allowing clinicians to verify, adjust, and approve every result.

Are there specific claims regarding the precision or accuracy benefits of using these tools?

1CMR Pro explicitly claims to achieve up to 40% higher precision than manual analysis for cardiac MRI measurements and is validated across multi-centre datasets. Autoplaque is described as providing AI-powered quantitative analysis, but a specific percentage for increased precision or accuracy compared to manual methods is not disclosed in the provided information.

What is the regulatory clearance status for each product?

Both Autoplaque and 1CMR Pro are FDA-cleared. Additionally, 1CMR Pro also holds CE Class IIB clearance.